Alpha Centric Advisors LLC Taro Pharmaceutical Industries LTD Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$23.0 - $31.59 $115,000 - $157,950
5,000 Added 18.18%
32,500 $790,000
Q4 2022

Feb 07, 2023
BUY
$27.6 - $32.99 $82,800 - $98,970
3,000 Added 12.24%
27,500 $799,000
Q3 2022

Nov 08, 2022
BUY
$28.74 - $39.9 $704,130 - $977,550
24,500 New
24,500 $735,000

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email